Unlocking
the future
of medicine

About us

Offering an unrivalled modular platform and tailored hyper-targeting is how we stand apart

Pipeline

Reducing the impact of cancer and infectious diseases on people’s lives is why we’re here

Innovation and research

Pushing the boundaries of human advancement in medicine is what drives us every day

Investors
 
 
 

A vaccine platform that unlocks unlimited possibilities for the future of medicine

The Nykode Therapeutics platform is built around the Vaccibody molecule. Inducing fast, strong and long-lasting immune responses, and demonstrating a positive safety profile, our pioneering Vaccibody™ vaccine has the potential to treat many disease areas, including cancer.

Highlights

Nykode Therapeutics – 4Q 2022 Financial Results – presentation

Read More
28 February 2023

Nykode Therapeutics to announce financial results for the fourth ...

Read More
22 February 2023

Nykode Therapeutics Announces Collaboration with The GOG Foundation, Inc. ...

Read More
10 February 2023

Nykode Therapeutics to Present at SVB Securities Global Biopharma ...

Read More
07 February 2023

Nykode Therapeutics – Presentation at the 41st Annual J.P. ...

Read More
09 January 2023

Nykode Therapeutics to Present at the 41st Annual J.P. ...

Read More
27 December 2022

Nycode Therapeutics – Clinical development plan for VB10.16 – ...

Read More
20 December 2022

Nykode Therapeutics announces expanded clinical development plan for its ...

Read More
20 December 2022

Nykode Therapeutics and Richter-Helm BioLogics Announce Strategic Manufacturing Partnership

Read More
19 December 2022